NCT03727321View on ClinicalTrials.gov

FMT and Fiber in Patients With Metabolic Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

January 16, 2020

Study Completion Date

January 16, 2020

Conditions
ObesityMetabolic Syndrome
Interventions
COMBINATION_PRODUCT

Fecal Microbial Transplant

Fecal microbiome transplant (FMT): 50grams of FMT from a single, universal donor will be administered in 20-30 capsules taken by mouth.

DIETARY_SUPPLEMENT

Fiber

A combination of soluble corn fiber (PROMITOR®: Tate\&Lyle), Resistant Wheat Starch 4 (Fibersym®: MGP Ingredients), and Acacia Gum (Pre-Hydrated Gum Arabic: TIC GUMS) for a total of 6 weeks (men 33g/day; women 27g/day)

DIETARY_SUPPLEMENT

Cellulose

Placebo will consist of cellulose powder (Microcrystalline cellulose:Blanver) in foil packets.

Trial Locations (2)

T5H 3V9

Royal Alexandra Hospital, Edmonton

T6G 2B7

University of Alberta Hospital, Edmonton

All Listed Sponsors
collaborator

The Weston A. Price Foundation

OTHER

lead

University of Alberta

OTHER

NCT03727321 - FMT and Fiber in Patients With Metabolic Syndrome | Biotech Hunter | Biotech Hunter